HHealthcare Read More Lilly sues six firms over alleged illegal sales of obesity drug retatrutideAugust 12, 2026 Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
AArtificial intelligence Read More Eaton jumps as its earnings and outlook signal hope for the AI buildoutJuly 31, 2026 Eaton delivered an excellent quarter on Friday, reinforcing our view that the AI data center buildout remains alive…
BBusiness Read More 5 things to know before the stock market opens TuesdayJuly 21, 2026 This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Tuesday. JetBlue won the…
AArtificial intelligence Read More Meta’s latest move in the AI talent war, plus Cramer’s 4 quick hitsJuly 17, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
AArtificial intelligence Read More The AI trade cooled and oil sank. A closer look at Wall Street’s volatile weekJune 27, 2026 Wall Street spent the week debating who the biggest winners and losers of the artificial intelligence boom will…
BBusiness Read More Rockets, satellites and Grok: What’s the right S&P sector for SpaceX?May 24, 2026 SpaceX is on the verge of going where no initial public offering has ever gone before. The company,…
AArtificial intelligence Read More Eaton’s stock sat out the AI boom this year. What can spark a rally in 2026January 1, 2026 Better things are ahead for Club name Eaton after its lackluster 2025 performance. Shares are on track for…